SCX and tuberous sclerosis: In our study we have shown that maintaining Scx localization in the nucleus using a RAR agonist does not necessarily induce tenogenic differentiation but is rather associated with the maintenance of the TSC phenotype, consistent with the inhibition of differentiation towards multiple mesenchymal lineages.